Our Mission

Empower embryologists to dramatically improve IVF success rates by improving sperm cell selection

To do so, QART Medical has developed a breakthrough solution for characterizing and selecting sperm cells.

The Team

Alon Shalev, MSc

Co-Founder, CEO


Alon Shalev, QART’s co-founder and CEO, brings his vast business and development experience in the medical device field.

22 years of experience as an Inventor, Technologist, Entrepreneur, and Executive in the MedTech sector including: Co-Founder and COO of BrainsGate (2000-2004), CEO of Nicast (2005-2007), Co-Founder and CEO of Endospan (2008-2017), Co-Founder and Executive Board Member of SynCath Neuroscience (2018-Present). MSc (cum laude) in Electrical Engineering from Tel-Aviv University.

Prof. Natan T. Shaked, PhD

Co-Founder, Chief Scientific Officer


Natan Shaked - QART’s co-founder and chief scientist, brings his immense research experience and know- how as well as his expertise with holographic imaging of sperm cells.

Natan has been an active researcher for over 18 years. Chair of Biomedical Engineering Department at Tel Aviv University, Israel. Visiting Assistant Professor in the Department of Biomedical Engineering at Duke University. Chair of the SPIE Label-Free Biomedical Imaging and Sensing (LBIS) Annual Conference in San Francisco. Fellow of the Optical Society of America (OSA). Author of over 90 peer-reviewed journal papers, over 160 conference papers, and chapters in several books.

Dr. Mattan Levi, PhD

Director of Translational Research


Mattan Levi, QART’s director of Translational research brings his vast practical medical experience with clinical embryology and IVF research. Mattan is an experienced clinical embryologist, founder and director of the medical andrology laboratory at Herzliya Medical Center. Received B.Sc. (magna cum laude), M.Sc. (summa cum laude) and Ph.D in Cell and Developmental Biology. Two decades of scientific research in the fields of reproductive and cancer biology including teaching embryology, histology and molecular Imaging at Tel Aviv University, a fellowship at Pierre et Marie Curie University, founding and managing the oncology research laboratory at Rabin Medical Center, publishing 30 peer-reviewed scientific articles, chapters in textbooks and invited reviews, and receiving prestigious international awards.

Shimon Oz, MBA

Chief Financial Officer


Shimon Oz, QART’s CFO, brings over 25 years of extensive financial and business management experience.

Shimon has served as a CFO, executive director, economic consultant, independent advisor, and investment banker for clients including Scitex Corp, Forum Film, Elan Jaglom Group, Mig Group, Infinity VC Group, Dekora Group and others. Shimon holds an MA in economics and an MBA (cum laude) from The Hebrew University of Jerusalem.

Arik Drori, MBA



Arik Drori, QART’s VP R&D, brings over 20 years’ experience in R&D with well-developed leadership and problem-solving skills. Arik is an innovator with out-of-the-box way of thinking.

Arik led system & development teams in Real-imaging, GE-Versamed, Optical-imaging, and more. Arik holds a BSc in electrical engineering from Tel-Aviv University, and MBA from Heriot-watt university in Scotland.

Orly Schwartz

VP QA, RA & Clinical Affairs


Orly Schwartz, VP QA, RA & Clinical Affairs brings over 18 years of operational and executive clinical & regulatory experience in MedTech.

Orly has managed multi-center, multi-continent clinical studies, submission to EU for CE marking, US FDA, PMDA Japan and AMAR Israel. Orly holds a BSc in Biomedical Engineering from Tel Aviv University.

Oren Lev, MBA

Director of Software Engineering


Oren Lev, QART’s Director of Software Engineering and Architecture, brings years of experience in SW design for medical devices and other fields.

Oren was CTO at FuturingUp, director of software at Real Imaging, and led design and development at BMC and Perion. Oren holds a BSc. (cum laude) in Aeronautics and Space Engineering, and an MBA, both from the Technion.

Dana Goldkorn

Algorithm engineer


Dana Goldkorn, QART’s SW and Algorithm engineer brings exceptional programming know-how and experience with holographic imaging.

Dana is finalizing her M.Sc in electrical engineering from Tel-Aviv university, developing image processing algorithms for holographic imaging.

Simcha K. Mirsky, PhD

Optics Design Leader

Simcha Mirsky, QART’s Optics Design Leader, has a PhD in biomedical engineering from Tel Aviv University and brings over 9 years of experience in holographic system design and image processing, with 22 peer-reviewed papers and 2 patents in this field.

Scientific Panel

Dr. Robert Wah, MD

Former President of American Medical Association (AMA). Former Global Chief Medical Officer @CSC (now DXC) for 12 Years. Served in the US Navy for 23 years including as Associate CIO for the Military Health System where he managed >$900M in annual Health IT spending at 520 hospitals covering 10M patients worldwide.

Professor Mitchell Rosen MD


An expert in reproductive endocrinology and fertility, serves as the Director of the UCSF Fertility Preservation Program, UCSF Health, San Francisco, USA

Dr. Susan Alpert, MD, PhD


Dr. Alpert acted as senior vice president and chief regulatory officer at Medtronic. Before that, Dr. Alpert was the Vice President of Regulatory Sciences at C.R. Bard. Dr. Alpert held multiple positions at the FDA including as director of the FDA’s Office of Device Evaluation. Dr. Alpert holds an MD from the University of Miami (Florida) and a Ph.D. from New York University.

Professor Tomer Avidor-Reiss, Ph.D.

University of Toledo, Ohio, USA. Studies subcellular organelles including the centriole, centrosome, and cilium; how they are formed, function, and are involved with infertility

Eliezer Girsh, PhD


Dr. Girsch is a senior biologist and embryologist with years of experience in working with sperm and ova. He is a clinical embryologist and andrologist and manager of the sperm lab and bank at Barzilay Medical Center.